BRPI1009823A2 - "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit." - Google Patents

"composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."

Info

Publication number
BRPI1009823A2
BRPI1009823A2 BRPI1009823A BRPI1009823A BRPI1009823A2 BR PI1009823 A2 BRPI1009823 A2 BR PI1009823A2 BR PI1009823 A BRPI1009823 A BR PI1009823A BR PI1009823 A BRPI1009823 A BR PI1009823A BR PI1009823 A2 BRPI1009823 A2 BR PI1009823A2
Authority
BR
Brazil
Prior art keywords
composition
kit
dispensing system
drug dispensing
composition set
Prior art date
Application number
BRPI1009823A
Other languages
English (en)
Inventor
Andremont Antoine
Lescure François
De Gunzburg Jean
Original Assignee
Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7 filed Critical Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7
Publication of BRPI1009823A2 publication Critical patent/BRPI1009823A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
BRPI1009823A 2009-03-13 2010-03-12 "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit." BRPI1009823A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16016209P 2009-03-13 2009-03-13
PCT/EP2010/053231 WO2010103119A1 (en) 2009-03-13 2010-03-12 Compositions and methods for elimination of gram-negative bacteria

Publications (1)

Publication Number Publication Date
BRPI1009823A2 true BRPI1009823A2 (pt) 2019-09-24

Family

ID=42153903

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009823A BRPI1009823A2 (pt) 2009-03-13 2010-03-12 "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."

Country Status (12)

Country Link
US (1) US20120058936A1 (pt)
EP (1) EP2405909A1 (pt)
JP (1) JP2012520268A (pt)
KR (1) KR20120004448A (pt)
CN (1) CN102413826A (pt)
AU (1) AU2010223233A1 (pt)
BR (1) BRPI1009823A2 (pt)
CA (1) CA2754604A1 (pt)
EA (1) EA201101319A1 (pt)
IL (1) IL214979A0 (pt)
MX (1) MX2011009548A (pt)
WO (1) WO2010103119A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012061902A1 (en) * 2010-11-12 2012-05-18 Monash University Micronised spray-dried particles comprising polymyxin
US20130323217A1 (en) 2010-12-22 2013-12-05 Da Volterra Compositions and methods for the controlled repopulation of gram-negative bacteria in the colon
CN103130881B (zh) * 2013-02-06 2014-09-10 王冬国 一种肺炎克雷伯菌的耐药新基因
US10682360B2 (en) 2014-01-27 2020-06-16 Susanne GARDNER Antimicrobial formulations and applications thereof
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
BR112017021225A2 (pt) * 2015-04-03 2018-06-26 Konkuk University Glocal Industry-Academic Collaboration Foundation composição antibacteriana, quasi-droga antibacteriana, aditivo alimentar antibacteriano contra bactérias gram-negativas resistentes a carbapenem, composição farmacêutica e composição alimentar
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN107184953A (zh) * 2017-05-22 2017-09-22 山东省科学院生物研究所 一种抗菌脂肽皮脂膜修复组合物及其应用
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN110179967A (zh) * 2019-05-28 2019-08-30 中国医药集团总公司四川抗菌素工业研究所 多粘菌素母核和一种抗生素的组合物及其应用
CN112316112A (zh) * 2020-11-30 2021-02-05 河南农业大学 阿奇霉素在逆转食品动物源致病菌抗生素耐药性的用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3494308A (en) 1967-11-14 1970-02-10 George S Perrin Composite article having portions simulating wood
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
US6235313B1 (en) 1992-04-24 2001-05-22 Brown University Research Foundation Bioadhesive microspheres and their use as drug delivery and imaging systems
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
NZ512496A (en) 1998-11-30 2003-02-28 Teva Pharma Ethanolate of azithromycin
ES2267549T3 (es) 1999-06-29 2007-03-16 Sandoz Ag Procedimiento para la produccion de azitromicina.
DE60133083D1 (de) 2000-01-04 2008-04-17 Teva Pharma Verfahren zur herstellung von azithromycin-dihydrat
EP1304326B1 (en) 2000-07-25 2006-03-15 Laboratorio Silanes, S.A. de C.V. Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
ES2172417B1 (es) 2000-07-31 2003-09-16 Sint Quimica Sa Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
DE60114028T2 (de) 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
CA2429639C (en) 2000-11-27 2009-07-14 Biochemie S.A. Stable azithromycin monohydrate
PT1390377E (pt) 2001-05-22 2006-06-30 Pfizer Prod Inc Nova forma cristalina da azitromicina
WO2006045156A1 (en) * 2004-10-29 2006-05-04 Monash University Therapy for multi-drug resistant microorganisms
US9149439B2 (en) * 2005-03-21 2015-10-06 Sandoz Ag Multi-particulate, modified-release composition
US20100028334A1 (en) * 2006-12-15 2010-02-04 Trustees Of Boston University Compositions and methods to potentiate colistin activity
DE102007009242A1 (de) 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit magensaftresistenter Wirkstoff-Matix
WO2009037264A2 (en) * 2007-09-17 2009-03-26 Da Volterra Colonic delivery of antimicrobial agents

Also Published As

Publication number Publication date
AU2010223233A1 (en) 2011-10-06
US20120058936A1 (en) 2012-03-08
CA2754604A1 (en) 2010-09-16
EA201101319A1 (ru) 2012-04-30
MX2011009548A (es) 2011-12-14
IL214979A0 (en) 2011-11-30
CN102413826A (zh) 2012-04-11
JP2012520268A (ja) 2012-09-06
KR20120004448A (ko) 2012-01-12
EP2405909A1 (en) 2012-01-18
WO2010103119A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
BRPI1009823A2 (pt) "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
BRPI1010772A2 (pt) composto,e, composição farmacêutica.
BRPI0719398A2 (pt) Composição farmacêutica.
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
DK1907037T3 (da) Medikamentdispenser.
BRPI0810646A2 (pt) " compostos farmacêuticos ".
IL206395A (en) N- Heterocyclic-7-Oxo-6-Sulphoxy-6,1-Diazabicyclo [1.2.3] Octane-2-Carboxamides and Pharmaceuticals Containing Them
BRPI0815773A2 (pt) composto, e, medicamento.
IL211400A0 (en) Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0715712A2 (pt) Composição farmacêutica
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
BRPI0719393A2 (pt) Composição farmacêutica
NL2000690A1 (nl) Gestabiliseerde farmaceutische samenstellingen omvattende fesoterodine.
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0812354A2 (pt) Composição farmacêutica não-aquosa.
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
IL206808A (en) Indolyl-pyridone history, their pharmaceutical preparations and their uses
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.